The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer
Abstract
Numerous epidemiological studies have evaluated the association between coffee consumption and risk of type 2 diabetes, coronary heart disease, and various cancers. This paper briefly reviews the evidence for a relation between coffee consumption and these conditions, with particular attention to methodological issues. Several early studies suggested that coffee consumption could result in a marked increase in risk of coronary heart disease and several types of cancer. However, more recent prospective cohort studies that are less prone to selection and information bias have not confirmed these findings. High consumption of unfiltered types of coffee, such as French press and boiled coffee, has been shown to increase low-density-lipoprotein-cholesterol concentrations. In addition, limiting caffeinated coffee intake during pregnancy seems a prudent choice. However, evidence has been accumulating that frequent consumption of coffee may reduce risk of type 2 diabetes and liver cancer. Further experimental studies are warranted to elucidate the underlying mechanisms and possibly identify the components in coffee that are responsible for these putative effects. In sum, the currently available evidence on coffee and risk of cardiovascular diseases and cancer is largely reassuring, and suggests that, for the general population, addressing other health-related behaviors has priority for the prevention of chronic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Willett, W. C. (1998) · doi:10.1093/acprof:oso/9780195122978.001.0001 · Cited by 4,541
meta-analysis bias in location and selection of studies
Egger, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7124.61 · Cited by 1,374
Feskanich, D., Rimm, E. B., Giovannucci, E. L., Colditz, G. A., Stampfer, M. J., Litin, L. B., & Willett, W. C. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)91754-e · Cited by 1,070
Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review
van Dam, R. M., & Hu, F. B. (2005) · JAMA · doi:10.1001/jama.294.1.97 · Cited by 662 · cited 1×
“van Dam et al. (2004a)”
Tolerance to the humoral and hemodynamic effects of caffeine in man.
Robertson, D., Wade, D., Workman, R., Woosley, R. L., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110124 · Cited by 501
Coffee, CYP1A2 genotype, and risk of myocardial infarction
Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H. (2006) · JAMA · doi:10.1001/jama.295.10.1135 · Cited by 490 · cited 1×
“caffeine-metabolizing cytochrome P450 1A2 (CYP1A2) enzyme (Cornelis et al. 2006).”
Coffee consumption and risk for type 2 diabetes mellitus
Salazar-Martinez, E., Willett, W. C., Ascherio, A., Manson, J. E., Leitzmann, M. F., Stampfer, M. J., & Hu, F. B. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00005 · Cited by 462
Noordzij, M., Uiterwaal, C. S., Arends, L. R., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000166828.94699.1d · Cited by 376 · cited 1×
“A meta-analysis of randomized trials with intervention durations of at least 7 days separately estimated the effect of caffeine (7 trials; median dose, 410 mg day–1) and caffeinated coffee (18 trials; median intake, 725 mL day–1) (Noordzij et al. 2005).”
Caffeine Can Decrease Insulin Sensitivity in Humans
Keijzers, G. B., De Galan, B. E., Tack, C. J., & Smits, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.364 · Cited by 358
Coffee, caffeine, and cardiovascular disease in men.
Grobbee, D. E., Rimm, E. B., Giovannucci, E., Colditz, G., Stampfer, M., & Willett, W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010113231504 · Cited by 322
Cited by
Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., & Hu, F. B. (2010) · Circulation · doi:10.1161/circulationaha.109.876185 · Cited by 1,641
Hu, F. B. (2013) · Obesity Reviews · doi:10.1111/obr.12040 · Cited by 884
The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases
Malik, V. S., & Hu, F. B. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00627-6 · Cited by 854
Besufkad, A., Worku, Y., Desalegn, F., & Aragaw, D. (2011) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.4172/2157 · Cited by 847
Tajik, N., Tajik, M., Mack, I., & Enck, P. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1379-1 · Cited by 803
Roles of Chlorogenic Acid on Regulating Glucose and Lipids Metabolism: A Review
Meng, S., Cao, J., Feng, Q., Peng, J., & Hu, Y. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/801457 · Cited by 586
A review on the beneficial aspects of food processing
van Boekel, M., Fogliano, V., Pellegrini, N., Stanton, C., Scholz, G., Lalljie, S., Somoza, V., Knorr, D., Jasti, P. R., & Eisenbrand, G. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900608 · Cited by 555
Ding, M., Bhupathiraju, S. N., Chen, M., van Dam, R. M., & Hu, F. B. (2014) · Diabetes Care · doi:10.2337/dc13-1203 · Cited by 511
Sugar-Sweetened Beverages and Cardiometabolic Health: An Update of the Evidence
Malik, V. S., & Hu, F. B. (2019) · Nutrients · doi:10.3390/nu11081840 · Cited by 410
Fructose and Cardiometabolic Health
Malik, V. S., & Hu, F. B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.025 · Cited by 408
Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation
Ong, K. W., Hsu, A., & Tan, B. K. H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.008 · Cited by 406
Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages
Malik, V. S., & Hu, F. B. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0259-6 · Cited by 327
Lifestyle factors in people seeking infertility treatment – A review
ANDERSON, K., NISENBLAT, V., & NORMAN, R. (2010) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2009.01119.x · Cited by 277
Vinayagam, R., Jayachandran, M., & Xu, B. (2016) · Phytotherapy Research · doi:10.1002/ptr.5528 · Cited by 267
Ong, K. W., Hsu, A., & Tan, B. K. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032718 · Cited by 261
Caffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188
Habitual Coffee Consumption and Risk of Heart Failure: A Dose-Response Meta-Analysis
Mostofsky, E., Rice, M. S., Levitan, E. B., & Mittleman, M. A. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.967299 · Cited by 185
Caffeine and creatine use in sport
Tarnopolsky, M. A. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000322696 · Cited by 130
Metadata
- Authors
- van Dam, R. M.
- Venue
- Applied Physiology, Nutrition, and Metabolism
- Publisher
- Canadian Science Publishing
- Published
- 2008-12
- Volume
- 33
- Issue
- 6
- Pages
- 1269-1283
- ISSN
- 1715-5312 (ISSN-L)
- 1715-5320
- OpenAlex
- W2112566574
- Cited by
- 162
- References
- 30
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.